Estimation of glomerular filtration rate based on serum cystatin c versus creatinine in a uruguayan population

International Journal of Nephrology

Volumn 2014, Issue , 2014, Pages

  Lujambio, Inés ^a   Sottolano, Mariana ^a   Luzardo, Leonella ^a   Robaina, Sebastián ^a   Krul, Nadia ^a   Thijs, Lutgarde ^b   Carusso, Florencia ^a   Da Rosa, Alicia ^a   Ríos, Ana Carina ^a   Olascoaga, Alicia ^a   Garau, Mariela ^c   Gadola, Liliana ^a   Noboa, Oscar ^a   Staessen, Jan A ^b,d   Boggia, José ^a  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934950523     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2014/837106     Document Type: Article

References (55)

1. A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, "A more accurate method to estimate glomerular fltration rate from serum creatinine: a new prediction equation," Annals of Internal Medicine, vol. 130, no. 6, pp. 461-470, 1999.
2. A. S. Levey, L. A. Stevens, C. H. Schmid et al., "A new equation to estimate glomerular fltration rate," Annals of Internal Medicine, vol. 150, no. 9, pp. 604-612, 2009.
3. L. A. Inker, C. H. Schmid, H. Tighiouart et al., "Estimating glomerular fltration rate from serum creatinine and cystatin C," New England Journal of Medicine, vol. 367, no. 1, pp. 20-29, 2012.
4. J. Kyhse-Andersen, C. Schmidt, G. Nordin et al., "Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular fltration rate," Clinical Chemistry, vol. 40, no. 10, pp. 1921-1926, 1994.
5. E. Premaratne, R. J. MacIsaac, S. Finch, S. Panagiotopoulos, E. Ekinci, and G. Jerums, "Serial measurements of cystatin c are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes," Diabetes Care, vol. 31, no. 5, pp. 971-973, 2008.
6. M. G. Shlipak, K. Matsushita, J. Ärnlöv et al., "Cystatin C versus creatinine in determining risk based on kidney function," The New England Journal of Medicine, vol. 369, pp. 932-943, 2013.
7. L. Fan, L. A. Inker, J. Rossert et al., "Glomerular fltration rate estimation using cystatin C alone or combined with creatinine as a confrmatory test," Nephrology Dialysis Transplantation, vol. 29, no. 6, pp. 1195-1203, 2014.
8. L. Luzardo, I. Lujambio, M. Sottolano et al., "Cohorte GEFA-HT-UY (GEnotipo, Fenotipo y Ambiente de la HiperTensión Arterial en UruguaY)," Revista Médica del Uruguay, vol. 29, pp. 103-113, 2013.
9. L. M. Van Bortel, E. J. Balkestein, J. J. van der Heijden-Spek et al., "Non-invasive assessment of local arterial pulse pressure: comparison of applanation tonometry and echo-tracking," Journal of Hypertension, vol. 19, no. 6, pp. 1037-1044, 2001.
10. C. H. Chen, E. Nevo, B. Fetics et al., "Estimation of Central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function," Circulation, vol. 95, no. 7, pp. 1827-1836, 1997.
11. A. L. Pauca, M. F. O'Rourke, and N. D. Kon, "Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform," Hypertension, vol. 38, no. 4, pp. 932-937, 2001.
12. L. M. van Bortel, S. Laurent, P. Boutouyrie et al., "Expert consensus document on the measurement of aortic stifness in daily practice using carotid-femoral pulse wave velocity," Journal of Hypertension, vol. 30, no. 3, pp. 445-448, 2012.
13. L. D. Bowers and E. T. Wong, "Kinetic serum creatinine assays. II. A critical evaluation and review," Clinical Chemistry, vol. 26, no. 5, pp. 555-561, 1980.
14. M. Peake and M. Whiting, "Measurement of serumcreatinine- current status and future goals," The Clinical Biochemist Reviews, vol. 27, no. 4, pp. 173-182, 2006.
15. G. L. Myers, W. G. Miller, J. Coresh et al., "Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program," Clinical Chemistry, vol. 52, no. 1, pp. 5-18, 2006.
16. "Laboratory evaluation-Creatinine Standardization Recommendations," Internet source, http://nkdep.nih.gov/.
17. A. S. Levey, J. Coresh, T. Greene et al., "Expressing the mod-ifcation of diet in renal disease study equation for estimating glomerular fltration rate with standardized serum creatinine values," Clinical Chemistry, vol. 53, no. 4, pp. 766-772, 2007.
18. A. S. Levey, J. Coresh, T. Greene, L. A. Stevens, Y. Zhang, and S. Hendriksen, "Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modifcation of Diet in Renal Disease study equation for estimating glomerular fltration rate (Annals of Internal Medicine (2006) 145, (247-254))," Annals of Internal Medicine, vol. 145, pp. 247-254, 2008.
19. J. M. Bland and D. G. Altman, "Statistical methods for assessing agreement between two methods of clinical measurement," The Lancet, vol. 1, no. 8476, pp. 307-310, 1986.
20. KDOQI Guidelines, http://www.kidney.org/.
21. J. R. Landis and G. G. Koch, "The measurement of observer agreement for categorical data," Biometrics, vol. 33, no. 1, pp. 159-174, 1977.
22. M. J. Pencina, S. D'Agostino, R. B. D'Agostino, and R. S. Vasan, "Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassifcation and beyond," Statistics in Medicine, vol. 27, no. 2, pp. 157-172, 2008.
23. M. J. Pencina, R. B. D'Agostino Sr., and E. W. Steyerberg, "Extensions of net reclassifcation improvement calculations to measure usefulness of new biomarkers," Statistics in Medicine, vol. 30, no. 1, pp. 11-21, 2011.
24. B. Bertoni, L. Jin, R. Chakraborty, and M. Sans, "Directional mating and a rapid male population expansion in a hybrid Uruguayan population," American Journal of Human Biology, vol. 17, no. 6, pp. 801-808, 2005.
25. C. Gascue, A. Mimbacas, M. Sans et al., "Frequencies of the four major Amerindian mtDNA haplogroups in the population of Montevideo, Uruguay," Human Biology, vol. 77, no. 6, pp. 873-878, 2005.
26. M. Sans, "'Race', ethnic and genetic adscription in Uruguay," Runa, vol. 30, no. 2, pp. 163-174, 2009.
27. V. R. Dharnidharka, C. Kwon, and G. Stevens, "Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis," American Journal of Kidney Diseases, vol. 40, no. 2, pp. 221-226, 2002.
28. E. Coll, A. Botey, L. Alvarez et al., "Serum cystatin C as a new marker for noninvasive estimation of glomerular fltration rate and as a marker for early renal impairment," American Journal of Kidney Diseases, vol. 36, no. 1, pp. 29-34, 2000.
29. H. Mangge, P. Liebmann, H. Tanil et al., "Cystatin C, an early indicator for incipient renal disease in rheumatoid arthritis," Clinica Chimica Acta, vol. 300, no. 1-2, pp. 195-202, 2000.
30. L. Pucci, S. Triscornia, D. Lucchesi et al., "Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients," Clinical Chemistry, vol. 53, no. 3, pp. 480-488, 2007.
31. K. Nitta, T. Hayashi, K. Uchida et al., "Serum cystatin C concentration as a marker of glomerular fltration rate in patients with various renal diseases," Internal Medicine, vol. 41, no. 11, pp. 931-935, 2002.
32. K. Soto, S. Coelho, B. Rodrigues et al., "Cystatin C as a marker of acute kidney injury in the emergency department," Clinical Journal of the American Society of Nephrology, vol. 5, no. 10, pp. 1745-1754, 2010.
33. Z. Zhang, B. Lu, X. Sheng, and N. Jin, "Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis," American Journal of Kidney Diseases, vol. 58, no. 3, pp. 356-365, 2011.
34. A. Spahillari, C. R. Parikh, K. Sint et al., "Serum cystatin C-versus creatinine-based defnitions of acute kidney injury following cardiac surgery: a prospective cohort study," The American Journal of Kidney Diseases, vol. 60, no. 6, pp. 922-929, 2012.
35. C. W. Tsai, M. E. Grams, L. A. Inker, J. Coresh, and E. Selvin, "Cystatin C-and creatinine-based estimated glomerular fltration rate, vascular disease, and mortality in persons with diabetes in the U.S.," Diabetes Care, vol. 37, no. 4, pp. 1002-1008, 2014.
36. M. E. Grams, S. P. Juraschek, E. Selvin et al., "Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine-and cystatin c-based estimates," American Journal of Kidney Diseases, vol. 62, no. 2, pp. 253-260, 2013.
37. P. Delanaye, E. Cavalier, O. Moranne, L. Lutteri, J. Krzesinski, and O. Bruyère, "Creatinine-or cystatin C-based equations to estimate glomerular fltration in the general population: impact on the epidemiology of chronic kidney disease," BMC Nephrology, vol. 14, no. 1, article 57, 2013.
38. H. S. Kilbride, P. E. Stevens, G. Eaglestone et al., "Accuracy of the MDRD (Modifcation of Diet in Renal Disease) study and CKD-EPI (CKD Epidemiology Collaboration) equations for estimation of GFR in the elderly," American Journal of Kidney Diseases, vol. 61, no. 1, pp. 57-66, 2013.
39. C. Pattaro, P. Riegler, G. Stifer, M. Modenese, C. Minelli, and P. P. Pramstaller, "Estimating the glomerular fltration rate in the general population using diferent equations: efects on classifcation and association," Nephron-Clinical Practice, vol. 123, no. 1-2, pp. 102-111, 2013.
40. N. V. Voskoboev, T. S. Larson, A. D. Rule, and J. C. Lieske, "Analytic and clinical validation of a standardized cystatin C particle enhanced turbidimetric assay (PETIA) to estimate glomerular fltration rate," Clinical Chemistry and Laboratory Medicine, vol. 50, no. 9, pp. 1591-1596, 2012.
41. M. Conde-Sánchez, E. Roldán-Fontana, N. Chueca-Porcuna, S. Pardo, and J. Porras-Gracia, "Analytical performance evaluation of a particle-enhanced turbidimetric cystatin C assay on the Roche COBAS 6000 analyzer," Clinical Biochemistry, vol. 43, no. 10-11, pp. 921-925, 2010.
42. L. A. Stevens, C. H. Schmid, T. Greene et al., "Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modifcation of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2," American Journal of Kidney Diseases, vol. 56, no. 3, pp. 486-495, 2010.
43. I. Masson, N. Maillard, I. Tack et al., "GFR estimation using standardized cystatin C in kidney transplant recipients," American Journal of Kidney Diseases, vol. 61, no. 2, pp. 279-284, 2013.
44. J.-F. Feng, L. Qiu, L. Zhang et al., "Multicenter study of creatinine-and/or cystatin C-based equations for estimation of glomerular fltration rates in Chinese patients with chronic kidney disease," PLoS ONE, vol. 8, no. 3, Article ID e57240, 2013.
45. M. Zhang, Y. Chen, L. Tang et al., "Applicability of chronic kidney disease epidemiology collaboration equations in a Chinese population," Nephrology, Dialysis, Transplantation, vol. 29, no. 3, pp. 580-586, 2014.
46. M. G. Shlipak, R. Katz, M. J. Sarnak et al., "Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease," Annals of Internal Medicine, vol. 145, no. 4, pp. 237-246, 2006.
47. M. G. Shlipak, M. J. Sarnak, R. Katz et al., "Cystatin C and the risk of death and cardiovascular events among elderly persons," The New England Journal of Medicine, vol. 352, no. 20, pp. 2049-2060, 2005.
48. W. Koenig, D. Twardella, H. Brenner, and D. Rothenbacher, "Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular fltration rate," Clinical Chemistry, vol. 51, no. 2, pp. 321-327, 2005.
49. T. Jernberg, B. Lindahl, S. James, A. Larsson, L.-O. Hansson, and L. Wallentin, "Cystatin C: a novel predictor of outcome in suspected or confrmed non-ST-elevation acute coronary syndrome," Circulation, vol. 110, no. 16, pp. 2342-2348, 2004.
50. C. A. Peralta, R. Katz, M. J. Sarnak et al., "Cystatin C identifes chronic kidney disease patients at higher risk for complications," Journal of the American Society of Nephrology, vol. 22, no. 1, pp. 147-155, 2011.
51. C. A. Peralta, M. G. Shlipak, S. Judd et al., "Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to endstage renal disease and mortality," The Journal of the American Medical Association, vol. 305, no. 15, pp. 1545-1552, 2011.
52. M. Madero, C. L. Wassel, C. A. Peralta et al., "Cystatin C associates with arterial stifness in older adults," Journal of the American Society of Nephrology, vol. 20, no. 5, pp. 1086-1093, 2009.
53. M. Odaira, H. Tomiyama, C. Matsumoto et al., "Association of serum cystatin C with pulse wave velocity, but not pressure wave refection, in subjects with normal renal function or mild chronic kidney disease," American Journal of Hypertension, vol. 23, no. 9, pp. 967-973, 2010.
54. S. H. Song, I. S. Kwak, Y. J. Kim et al., "Serum cystatin C is related to pulse wave velocity even in subjects with normal serum creatinine," Hypertension Research, vol. 31, no. 10, pp. 1895-1902, 2008.
55. Censo Nacional 2011, http://www.ine.gub.uy/censos2011/index.html.